Raymond James analyst Srini Pajjuri assumes Broadcom (NASDAQ:AVGO) with a Market Perform rating.
Syndax Late Tuesday Announced it Priced ~6.8M Public Share Offering of Common Stock @$22/Share
Syndax Pharmaceuticals, Inc. ("Syndax," the "Company" or "we") (NASDAQ: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced the pricing of an underwritten public offering of 6,818,182 shares of its common stock.